KRMD

KORU Medical Systems, Inc. Common Stock (DE)

KRMD
Closed
$4.28
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Mahwah, New Jersey and currently employs 73 full-time employees. The firm is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The firm is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
Country

US

CEO

Ms. Linda Tharby

IPO date

1993

Employees

73

ISIN

US7599101026

Key stats

Open

$4.43

Volume

72.86K

Market cap

$203.48M

Prev. close

$4.43

Impl / hst vl

-

Open interest

$0.00

$4.23

Day’s Range

$4.45

$3.80

52W Range

$5.96

Valuation

50
Valuation score
Fairly Valued
P/E
-
P/S
4.70
P/B
12.02
Current ratio
2.33
Debt / Equity
-0.51
ROE
-13.61%
Gross margin
61.47%
Income growth
65.76%
FCF growth
-111.28

Analysts estimates

Consensus rating
Buy

The average rating from top 7 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$6.94
The top 7 analysts forecasts that 12-month price may increase by 62.06%, with a low of $5.05 and a high of $8.40
$5.05
Low
$6.94
Avg
$8.40
High
Current price

Earnings

Q1 ‘26 revenue
$11.76M
Q1 ‘26 net income
-$807.10K
Revenue
Net income
Previous EPS
-$0.02
Estimate EPS
-$0.02
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply